You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KIT-Mutant

Showing 1 - 25 of 1,445
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

Gastrointestinal Stromal Tumor of Rectum Trial in Fuzhou (Imatinib Mesylate, Local resection)

Not yet recruiting
  • Gastrointestinal Stromal Tumor of Rectum
  • Imatinib Mesylate
  • Local resection
  • Fuzhou, Fujian, China
    Weizhong Jiang
Jul 23, 2023

Melanoma Trial in Shinjuku (Pembrolizumab and Imatinib mesylate)

Recruiting
  • Melanoma
  • Pembrolizumab and Imatinib mesylate
  • Shinjuku, Tokyo, Japan
    Keio University Hospital
Mar 29, 2022

Melanoma Trial in Beijing, Guangzhou, Seoul (PLX3397)

Active, not recruiting
Has Results
  • Melanoma
  • Beijing, Beijing, China
  • +4 more
Apr 21, 2022

Malignant Melanoma Trial in United Kingdom (PLX3397)

Completed
  • Malignant Melanoma
  • Manchester, Greater Manchester, United Kingdom
  • +7 more
Aug 11, 2021

Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • +2 more
    • (no location specified)
    Jul 15, 2022

    Cancer, Lung, Cancer of Esophagus, Cancer of Head and Neck Trial in Hualien City

    Recruiting
    • Cancer, Lung
    • +2 more
      • Hualien City, Taiwan
        Hualien Tzu Chi Hospital
      Sep 12, 2022

      Metastatic or Unresectable Gastrointestinal Stromal Tumors

      Not yet recruiting
      • Gastrointestinal Stromal Tumors
      • +2 more
        • (no location specified)
        Jul 16, 2022

        Glioma, Malignant, Computer-Assisted Trial in Shanghai (Validation of IDH1 mutations from the radiomics model)

        Active, not recruiting
        • Glioma, Malignant
        • Computer-Assisted
        • Validation of IDH1 mutations from the radiomics model
        • Shanghai, Shanghai, China
          Huashan Hospital, Fudan University
        Jul 23, 2023

        A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

        Not yet recruiting
        • C-KIT Mutation
          • (no location specified)
          Nov 2, 2023

          Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

          Recruiting
          • Core Binding Factor Acute Myeloid Leukemia
          • KIT Mutation-Related Tumors
          • Suzhou, Jiangsu, China
            First Affiliated Hospital of Soochow University
          Apr 7, 2023

          Hyperferritinemia Candidate Gene

          Recruiting
          • Hyperferritinemia
          • Genetic analysis
          • Monza, MB, Italy
            Centre for Rare Disease - Disorders of Iron Metabolism, ASST-Mon
          Jan 17, 2023

          Human Papilloma Virus Infection Trial in Jakarta (HPV Diagnostic Kit (Bio Farma))

          Completed
          • Human Papilloma Virus Infection
          • HPV Diagnostic Kit (Bio Farma)
          • Jakarta, DKI Jakarta, Indonesia
            Cipto Mangunkusumo Hospital
          Oct 26, 2023

          Advance NSCLC Trial (GFH925, Cetuximab)

          Not yet recruiting
          • Advance Non-small Cell Lung Cancer
          • (no location specified)
          Mar 7, 2023

          The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer

          Not yet recruiting
          • Lung Cancer
            • (no location specified)
            Sep 13, 2022

            Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC

            Recruiting
            • Non-small Cell Lung Cancer
              • Guanzhou, China
                Sun Yat-sen University Cancer Center
              Aug 11, 2023

              Mild Intellectual Disability, Borderline Intellectual Functioning Trial in San Francisco (D-kit/EF1, Sham group program)

              Not yet recruiting
              • Mild Intellectual Disability
              • Borderline Intellectual Functioning
              • D-kit/EF1
              • Sham group program
              • San Francisco, California
                UCSF Nancy Friend Pritzker Psychiatry Building
              Jun 27, 2023

              NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

              Recruiting
              • Non-small Cell Lung Cancer (NSCLC)
              • +3 more
              • San Antonio, Texas
              • +1 more
              Sep 8, 2023

              Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)

              Not yet recruiting
              • Low Grade Glioma of Brain
              • PEPIDH1M vaccine + vorasidenib
              • Durham, North Carolina
                Duke University Medical Center
              Nov 2, 2022

              Hepatocellular Carcinoma Trial (GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescent PCR Method))

              Not yet recruiting
              • Hepatocellular Carcinoma
              • GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
              • (no location specified)
              Dec 25, 2022

              First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

              Completed
              • BRAF V600E Mutation Positive
              • Metastatic Colorectal Cancer
              • Non Interventional study
              • St. Veit/Glan, Austria
              • +33 more
              Jan 20, 2023

              Esophageal Tumors Trial (KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method))

              Not yet recruiting
              • Esophageal Neoplasms
              • KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
              • (no location specified)
              Dec 25, 2022

              Acute Kidney Injury Trial in Singapore (AKI risk screening using RenaFAST POCT test kits)

              Recruiting
              • Acute Kidney Injury
              • AKI risk screening using RenaFAST POCT test kits
              • Singapore, Singapore
                National University Hospital
              Nov 6, 2023

              GIST Trial (Ripretinib, Sunitinib)

              Not yet recruiting
              • GIST
              • (no location specified)
              Feb 8, 2023

              Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in

              Not yet recruiting
              • Knee Osteoarthritis
                • (no location specified)
                Aug 28, 2023